# MVP v1 Completion Note

## Status

MVP v1 is functionally complete as of tag `v0.1.0-mvp`.

- Tag: `v0.1.0-mvp`
- Commit: `cefd55b813c98269a6862c579d5ccd951854a61d`
- Full test suite: `147 passed`
- Completion checkpoint: passed
- Manual smoke output check: passed
- Negative smoke output check: passed

This note records the stable MVP v1 baseline before any post-MVP source expansion, persistence layer, scheduler, alerting, or advanced report generation work.

---

## Active MVP v1 Sources

MVP v1 is intentionally limited to:

- FDA
- TFDA
- ClinicalTrials.gov

Do not expand MVP v1 to EMA, NMPA/CDE, PMDA, WHO ICTRP, EU CTIS, literature, patents, finance, or commercial intelligence unless explicitly approved in a later phase.

---

## MVP v1 MCP Tool Status

| MCP Tool | MVP v1 Status | Notes |
|---|---|---|
| `search_regulatory_updates` | Implemented | FDA and TFDA regulatory update search. |
| `get_regulatory_document_detail` | Implemented, metadata-backed | Reconstructs detail from normalized search metadata; full document body and attachment parsing are not implemented yet. |
| `compare_regulatory_updates` | Implemented, metadata-backed | Compares FDA / TFDA updates descriptively; does not establish final regulatory interpretation. |
| `search_clinical_trials_by_indication` | Implemented | Uses ClinicalTrials.gov API v2 only. |
| `compare_companies_by_indication` | Implemented, minimal MVP aggregation | Compares sponsor-name-based ClinicalTrials.gov trial activity by indication. |
| `check_source_health` | Implemented | Checks FDA, TFDA, and ClinicalTrials.gov source health. |
| `list_source_failures` | Implemented, current snapshot | Converts current source health results into failure records; no historical event store. |
| `generate_regulatory_digest` | Implemented, minimal MVP aggregation | Generates a rule-based digest from existing regulatory search, clinical trial search, source health, and source failure outputs. |

---

## Key MVP v1 Guardrails

The system should remain conservative.

It must not infer:

- Clinical success
- Regulatory approval probability
- Commercial strength
- Company superiority
- Final agency equivalence
- Final regulatory requirement mapping

All outputs should preserve source metadata, query metadata, and known limitations where applicable.

---

## Known MVP v1 Limitations

- `get_regulatory_document_detail` is metadata-backed only.
- `compare_regulatory_updates` is descriptive and metadata-backed.
- `search_clinical_trials_by_indication` uses ClinicalTrials.gov only.
- `compare_companies_by_indication` is sponsor-name-based and does not infer corporate family relationships.
- `compare_companies_by_indication` records `date_range` in metadata, but date-based trial filtering is not applied in MVP v1.
- `list_source_failures` is a current health snapshot, not a persisted historical failure event store.
- `generate_regulatory_digest` is a rule-based MVP aggregation, not a final regulatory, clinical, legal, or medical assessment.
- Impact matrix output is heuristic and requires manual review.

---

## Validation Summary

The following checks passed before creating the MVP tag:

- `python -m pytest -q`
- Result: `147 passed`

Manual smoke run confirmed all 8 tools returned structured `STATUS: OK` outputs.

Negative smoke run confirmed degraded source behavior is structured and visible:

- `check_source_health` reports degraded source status.
- `list_source_failures` reports open failure records.
- `generate_regulatory_digest` reflects source health warning and open failure count.

---

## Recommended Next Phase

Do not immediately expand sources.

Recommended next phase options:

1. Improve manual examples and sample prompts.
2. Add post-MVP backlog planning.
3. Consider controlled source expansion only through a separate approved phase.
4. Keep all post-MVP work PR-based and scope-limited.

